Characterising airway obstructive, dysanaptic and PRISm phenotypes of prematurity-associated lung disease.

Further to airway obstruction, we describe airway dysanapsis and pPRISm spirometry phenotypes in survivors of prematurity, both of which have poor outlook in other disease groups. By identifying specific phenotypes, targeted therapy can be developed to improve long-term outcomes.